Log In
Print this Print this

therascreen EGFR RGQ PCR Kit, therascreen EGFR RGQ Plasma PCR Kit

  Manage Alerts
Collapse Summary General Information
Company Qiagen N.V.
DescriptionLiquid biopsy-based molecular assay for detection of EGFR mutation in NSCLC patients from plasma samples
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect EGFR mutation
Regulatory Designation
PartnerAstraZeneca plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today